Literature DB >> 17189391

Chips to bedside: incorporation of microarray data into clinical practice.

Lajos Pusztai1.   

Abstract

Mesh：

Year:  2006        PMID： 17189391     DOI： 10.1158/1078-0432.CCR-06-2649

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  10 in total

Review 1.  Metastatic gene signatures and emerging novel prognostic tests in the management of early stage breast cancer.

Authors:  Attila Tordai; Cornelia Liedtke; Lajos Pusztai
Journal:  Clin Exp Metastasis       Date:  2009-04-18       Impact factor: 5.150

2.  Rac3 regulates cell proliferation through cell cycle pathway and predicts prognosis in lung adenocarcinoma.

Authors:  Gebang Wang; Huan Wang; Chenlei Zhang; Tieqin Liu; Qingchang Li; Xuyong Lin; Jingwei Xie; Hongxu Liu
Journal:  Tumour Biol       Date:  2016-07-11

3.  BIOPHYSICAL PROPERTIES OF NUCLEIC ACIDS AT SURFACES RELEVANT TO MICROARRAY PERFORMANCE.

Authors:  Archana N Rao; David W Grainger
Journal:  Biomater Sci       Date:  2014-04-01       Impact factor: 6.843

4.  Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.

Authors:  Bjørn Naume; Xi Zhao; Marit Synnestvedt; Elin Borgen; Hege Giercksky Russnes; Ole Christian Lingjaerde; Maria Strømberg; Gro Wiedswang; Gunnar Kvalheim; Rolf Kåresen; Jahn M Nesland; Anne-Lise Børresen-Dale; Therese Sørlie
Journal:  Mol Oncol       Date:  2007-04-04       Impact factor: 6.603

Review 5.  Translating genomics into clinical practice: applications in lung cancer.

Authors:  Aubrey Jolly Graham; Anil Potti
Journal:  Curr Oncol Rep       Date:  2009-07       Impact factor: 5.075

6.  MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype.

Authors:  Wei Yan; Yanwei Liu; Pei Yang; Zheng Wang; Yongping You; Tao Jiang
Journal:  Oncotarget       Date:  2015-05-10

7.  Clustering gene expression regulators: new approach to disease subtyping.

Authors:  Mikhail Pyatnitskiy; Ilya Mazo; Maria Shkrob; Elena Schwartz; Ekaterina Kotelnikova
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

8.  Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.

Authors:  Joseph Andrews; Wendy Kennette; Jenna Pilon; Alexandra Hodgson; Alan B Tuck; Ann F Chambers; David I Rodenhiser
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

9.  A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop.

Authors:  Daniel D Von Hoff; Gary M Clark; Charles A Coltman; Mary L Disis; S G Eckhardt; Lee M Ellis; Margaret Foti; Elizabeth Garrett-Mayer; Mithat Gönen; Manuel Hidalgo; Susan G Hilsenbeck; John H Littlefield; Patricia M LoRusso; H Kim Lyerly; Neal J Meropol; Jyoti D Patel; Steven Piantadosi; Dean A Post; Meredith M Regan; Yu Shyr; Margaret A Tempero; Joel E Tepper; Jamie Von Roenn; Louis M Weiner; Donn C Young; Nu V Vu
Journal:  Clin Cancer Res       Date:  2021-07-26       Impact factor: 12.531

10.  Evaluation of data discretization methods to derive platform independent isoform expression signatures for multi-class tumor subtyping.

Authors:  Segun Jung; Yingtao Bi; Ramana V Davuluri
Journal:  BMC Genomics       Date:  2015-11-10       Impact factor: 3.969
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.